Causeway Capital Management LLC Dr Reddys Laboratories LTD Transaction History

Causeway Capital Management LLC

$3.06 Billion
Q4 2024

A detailed history of Causeway Capital Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Causeway Capital Management LLC holds 539,305 shares of RDY stock, worth $7.12 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

539,305

Previous 107,861 400.0%

Holding current value

$7.12 Million

Previous $8.57 Million 0.63%

% of portfolio

0.28%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$13.99 - $79.75 $6.04 Million - $34.4 Million	431,444 Added 400.0%	539,305 $8.52 Million
Q3 2024 Nov 13, 2024	BUY	$75.41 - $84.21 $127,216 - $142,062	1,687 Added 1.59%	107,861 $8.57 Million
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $618,708 - $690,586	-9,064 Reduced 7.87%	106,174 $8.09 Million
Q3 2023 Nov 09, 2023	SELL	$61.9 - $72.77 $2.15 Million - $2.53 Million	-34,744 Reduced 23.17%	115,238 $7.71 Million
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $585,886 - $693,200	-10,984 Reduced 6.82%	149,982 $9.47 Million
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $3.11 Million - $3.42 Million	60,144 Added 59.65%	160,966 $9.16 Million
Q4 2022 Feb 13, 2023	BUY	$51.15 - $57.45 $759,730 - $853,304	14,853 Added 17.28%	100,822 $5.22 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $1.93 Million - $2.22 Million	38,716 Added 81.93%	85,969 $4.5 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $1.12 Million - $1.31 Million	-22,505 Reduced 32.26%	47,253 $2.62 Million
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $25,534 - $34,517	-529 Reduced 0.75%	69,758 $3.89 Million
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $657,653 - $743,314	-11,053 Reduced 13.59%	70,287 $4.6 Million
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $4.92 Million - $6.15 Million	-81,719 Reduced 50.12%	81,340 $5.3 Million
Q2 2021 Aug 13, 2021	BUY	$62.12 - $74.2 $76,407 - $91,266	1,230 Added 0.76%	163,059 $12 Million
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $1.88 Million - $2.37 Million	-32,477 Reduced 16.71%	161,829 $9.94 Million
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $210,995 - $240,247	-3,370 Reduced 1.7%	194,306 $13.9 Million
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $2.61 Million - $3.68 Million	50,796 Added 34.58%	197,676 $13.8 Million
Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $413,890 - $571,912	-10,465 Reduced 6.65%	146,880 $7.79 Million
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $3.83 Million - $5.06 Million	110,300 Added 234.46%	157,345 $6.35 Million
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $175,249 - $197,595	5,033 Added 11.98%	47,045 $1.78 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $42,827 - $50,798	-1,188 Reduced 2.75%	42,012 $1.57 Million
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $1.69 Million - $2.09 Million	-52,843 Reduced 55.02%	43,200 $1.41 Million
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $2.89 Million - $3.62 Million	96,043	96,043 $3.43 Million

Others Institutions Holding RDY

# of Institutions

264

Shares Held

106M

Call Options Held

71K

Put Options Held

22.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.19B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Causeway Capital Management LLC with notifications on news.

Account

Causeway Capital Management LLC Dr Reddys Laboratories LTD Transaction History